Mount Carmel Health CEO resigns in wake of investigation into fatal overdoses

The CEO of Mount Carmel Health System announced his resignation following an internal investigation into a physician charged with murder in the deaths of dozens of hospitalized patients. (Mount Carmel)

The CEO of Mount Carmel Health System announced his resignation following an internal investigation into a physician charged with murder in the deaths of dozens of hospitalized patients by ordering fatal doses of painkillers. 

Ed Lamb—who has led the Ohio health system that is part of Trinity Health since 2016—will step down July 25, he said in a statement posted online (PDF).

Lamb also said 23 colleagues at the hospital, including five physicians, would be terminated from their roles. The move comes following an examination of the roles of those involved in the medication administration for the affected patients. He also said 11 employees would be allowed to return to work after completing additional training and education.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

RELATED: Ohio doctor charged with murder in deaths of 25 hospitalized patients

"While the changes implemented throughout our system already are significant, I am personally compelled to do all that I can to move Mount Carmel beyond this tragedy," Lamb said. "This was a difficult decision, but one that is in the best interest of our organization, our colleagues and the people we serve."

Court case

Lamb said the hospital is seeking to reach settlements. 

"We are deeply sorry for the additional grief and frustration this has caused and are working to provide reasonable settlements with affected families. If that cannot be accomplished, we will work through the court process," he said in the statement. "While we will continue to be forthcoming on changes we make to our system to strengthen patient safety and quality of care, we will not be able to comment on the legal cases except through the legal forum."

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Ochsner Health System is partnering with Color to launch a population health pilot program to integrate genetic information into preventive care.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options.